Cargando…

Integrated analysis of methylation-driven genes and pretreatment prognostic factors in patients with hepatocellular carcinoma

BACKGROUND: The potential reversibility of aberrant DNA methylation indicates an opportunity for oncotherapy. This study aimed to integrate methylation-driven genes and pretreatment prognostic factors and then construct a new individual prognostic model in hepatocellular carcinoma (HCC) patients. ME...

Descripción completa

Detalles Bibliográficos
Autores principales:	He, Dongsheng, Liao, Shengyin, Cai, Lifang, Huang, Weiming, Xie, Xuehua, You, Mengxing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8146257/ https://www.ncbi.nlm.nih.gov/pubmed/34034705 http://dx.doi.org/10.1186/s12885-021-08314-5

Ejemplares similares

Prognostic value of fatty acid metabolism-related genes in patients with hepatocellular carcinoma
por: He, Dongsheng, et al.
Publicado: (2021)

Prognostic Value of a Ferroptosis-Related Gene Signature in Patients With Head and Neck Squamous Cell Carcinoma
por: He, Dongsheng, et al.
Publicado: (2021)

The Prognostic Significance of Nomogram-Based Pretreatment Inflammatory Indicators in Patients With Esophageal Squamous Cell Carcinoma Receiving Intensity-Modulated Radiotherapy
por: Xu, Zhiyang, et al.
Publicado: (2023)

DNA methylation-driven genes for constructing diagnostic, prognostic, and recurrence models for hepatocellular carcinoma
por: Long, Junyu, et al.
Publicado: (2019)

Prognostic significance of pretreatment albumin/globulin ratio in patients with hepatocellular carcinoma
por: Deng, Yan, et al.
Publicado: (2016)

Pretreatment neutrophil–lymphocyte ratio: useful prognostic biomarker in hepatocellular carcinoma
por: Najjar, Marc, et al.
Publicado: (2018)

Complete and durable response to crizotinib in a patient with malignant pleural mesothelioma harboring CD74-ROS1 fusion
por: Xie, Xuehua, et al.
Publicado: (2022)

Clinical and prognostic implications of pretreatment albumin to C-reactive protein ratio in patients with hepatocellular carcinoma
por: Wu, Mian-Tao, et al.
Publicado: (2019)

Identification and analysis of DNA methylation-driven signatures for prognostic and immune microenvironments evaluation in hepatocellular carcinoma
por: Shen, Bingbing, et al.
Publicado: (2022)

Identification of Key Genes and Prognostic Value Analysis in Hepatocellular Carcinoma by Integrated Bioinformatics Analysis
por: Wang, Meng, et al.
Publicado: (2019)

A Four-Methylated lncRNAs-Based Prognostic Signature for Hepatocellular Carcinoma
por: Liao, Le-En, et al.
Publicado: (2020)

Prognostic and clinicopathologic significance of SIRT1 expression in hepatocellular carcinoma
por: Jiang, Hongyuan, et al.
Publicado: (2016)

Prognostic value of pretreatment (18)F-FDG PET-CT in radiotherapy for patients with hepatocellular carcinoma
por: Jo, In Young, et al.
Publicado: (2015)

Prognostic significance of pretreatment plasma fibrinogen in patients with hepatocellular and pancreatic carcinomas: A meta-analysis
por: Ji, Rui, et al.
Publicado: (2018)

Prognostic value of pretreatment skeletal muscle index in pancreatic carcinoma patients: A meta-analysis
por: Yang, Li, et al.
Publicado: (2023)

Identification and Characterization of Alcohol-related Hepatocellular Carcinoma Prognostic Subtypes based on an Integrative N6-methyladenosine methylation Model
por: Zhang, Yue, et al.
Publicado: (2021)

Prognostic value of aberrantly expressed methylation genes in human hepatocellular carcinoma
por: Zhen, Limin, et al.
Publicado: (2020)

Identification and Characterization of Alcohol-related Hepatocellular Carcinoma Prognostic Subtypes based on an Integrative N6-methyladenosine methylation Model: Erratum
por: Zhang, Yue, et al.
Publicado: (2022)

Immunological Significance of Prognostic DNA Methylation Sites in Hepatocellular Carcinoma
por: Xu, Qianhui, et al.
Publicado: (2021)

Methylation-Driven Genes Identified as Novel Prognostic Indicators for Thyroid Carcinoma
por: Lv, Liting, et al.
Publicado: (2020)

DNA methylation biomarkers for hepatocellular carcinoma
por: Fan, Guorun, et al.
Publicado: (2018)

Association of the pretreatment lung immune prognostic index with immune checkpoint inhibitor outcomes in patients with advanced hepatocellular carcinoma
por: Sun, Tao, et al.
Publicado: (2023)

Identification and validation of methylation-driven genes prognostic signature for recurrence of laryngeal squamous cell carcinoma by integrated bioinformatics analysis
por: Cui, Jie, et al.
Publicado: (2020)

Integrative epigenomic and genomic filtering for methylation markers in hepatocellular carcinomas
por: Shen, Jing, et al.
Publicado: (2015)

Cell-free methylation markers with diagnostic and prognostic potential in hepatocellular carcinoma
por: Lu, Chang-Yi, et al.
Publicado: (2016)

N6-Methyladenosine RNA Methylation Regulators Have Clinical Prognostic Values in Hepatocellular Carcinoma
por: Liu, Wei, et al.
Publicado: (2020)

Prognostic Biomarker Identification Through Integrating the Gene Signatures of Hepatocellular Carcinoma Properties
por: Cai, Jialin, et al.
Publicado: (2017)

Prognostic Value of DNA Methylation-Driven Genes in Clear Cell Renal Cell Carcinoma: A Study Based on Methylation and Transcriptome Analyses
por: Hu, Maolin, et al.
Publicado: (2020)

Pretreatment Neutrophil-to-Lymphocyte Ratio as Prognostic Biomarkers in Patients with Unresectable Hepatocellular Carcinoma Treated with Hepatic Arterial Infusion Chemotherapy Combined with Lenvatinib and Camrelizumab
por: Xiao, Yongqiang, et al.
Publicado: (2023)

Construction and validation of a prognostic signature using CNV-driven genes for hepatocellular carcinoma
por: Bian, Jin, et al.
Publicado: (2021)

Identification of HBV-MLL4 Integration and Its Molecular Basis in Chinese Hepatocellular Carcinoma
por: Dong, Hua, et al.
Publicado: (2015)

Pretreatment prognostic factors of survival and late toxicities for patients with nasopharyngeal carcinoma treated by simultaneous integrated boost intensity-modulated radiotherapy
por: Lin, Yun-Hsuan, et al.
Publicado: (2018)

Methylation of S100A8 is a promising diagnosis and prognostic marker in hepatocellular carcinoma
por: Liu, Kun, et al.
Publicado: (2016)

Four methylation‐driven genes may be prognostic biomarkers in clear cell renal carcinoma
por: Yin, Hang, et al.
Publicado: (2020)

Methylation-Driven Gene PLAU as a Potential Prognostic Marker for Differential Thyroid Carcinoma
por: Wu, Min, et al.
Publicado: (2022)

Quantitative analysis of APC promoter methylation in hepatocellular carcinoma and its prognostic implications
por: XU, BAIYING, et al.
Publicado: (2014)

Construction and Validation of Novel Diagnostic and Prognostic DNA Methylation Signatures for Hepatocellular Carcinoma
por: Li, Ran, et al.
Publicado: (2020)

Transcription Factors and Methylation Drive Prognostic miRNA Dysregulation in Hepatocellular Carcinoma
por: Qin, Shijie, et al.
Publicado: (2021)

ABHD12 contributes to tumorigenesis and sorafenib resistance by preventing ferroptosis in hepatocellular carcinoma
por: Cai, Mengxing, et al.
Publicado: (2023)

Association of the Pretreatment Lung Immune Prognostic Index with Survival Outcomes in Advanced Hepatocellular Carcinoma Patients Treated with PD-1 Inhibitors
por: Chen, Shixue, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_e9h8svmof2h94ci8oocqko5i6h